NEWS RELEASE-Immediate Release:

2020

Following guidance from the CDC and FDA, TCRHCC is pausing administration of Johnson & Johnson (J&J) vaccines. 

CDC and FDA are reviewing 6 cases of blood clots in individuals after receiving the J&J vaccine. These rare and severe blood clots were identified in women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. As of April 12th, more than 6.8 million doses of the J&J vaccine have been administered across the U.S. This step by the CDC and FDA shows that the federal oversight process for vaccine safety is working, and provides confidence that the Pfizer and Moderna vaccines continue to be safe and effective. Individuals should still get vaccinated with the Pfizer and Moderna vaccines as soon as possible. 

We will provide updates on the J&J vaccine when available. You may find additional guidance on the CDC website. If you received the J&J vaccine and have any health concerns, particularly severe headaches, abdominal pain, leg pain or shortness of breath within 3 weeks of vaccination, please contact a health care provider.” 

You may also refer to the FDA/CDC statement here: If further questions are asked, you may refer to the CDC/FDA statement here:

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine | FDA

 

# # # #